Excerpt from: Pancreatic Cancer Action Network (click for full article)
President Barack Obama made history in the fight against pancreatic cancer by signing the Recalcitrant Cancer Research Act into law. The legislation, formerly known as the Pancreatic Cancer Research and Education Act, passed the U.S. Congress on December 21 after it was attached to the National Defense Authorization Act.
The landmark legislation requires the National Cancer Institute (NCI) to examine its current research efforts on cancers with very low survival rates and work to develop early detection methods and better treatment options to help improve outcomes for those diagnosed with the most deadly forms of cancer, including pancreatic and lung cancer.
“The adoption of the Recalcitrant Cancer Research Act is a historic victory in the fight against deadly cancers—particularly pancreatic cancer—as it is the first legislation designed specifically with the disease in mind,” said Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network. “On behalf of thousands of pancreatic cancer advocates and patients around the country, we are deeply grateful for the incredible bipartisan support in Congress and to President Obama for signing the bill into law.”
Comments